| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Barrie Condon | |
| P2860 | cites work | Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses | Q24288978 |
| The clinical use of structural MRI in Alzheimer disease | Q24609648 | ||
| Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis | Q28255391 | ||
| Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis | Q31001850 | ||
| Depressive psychosis: clinical usefulness of MR spectroscopy data in predicting prognosis | Q31027365 | ||
| Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis | Q32182502 | ||
| Incidental findings at MRI-enterography in patients with suspected or known Crohn's disease. | Q33565007 | ||
| Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates | Q33591798 | ||
| Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis | Q33767237 | ||
| Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience | Q36624902 | ||
| A meta-analysis of hippocampal atrophy rates in Alzheimer's disease | Q37112259 | ||
| Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study | Q37550195 | ||
| Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis | Q39809906 | ||
| Incidental findings in healthy control research subjects using whole-body MRI. | Q40042708 | ||
| Severe ADC decreases do not predict irreversible tissue damage in humans | Q40667689 | ||
| Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study | Q43277678 | ||
| Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. | Q44335697 | ||
| Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response | Q46323670 | ||
| Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer | Q46502892 | ||
| Measurement of tumor "size" in recurrent malignant glioma: 1D, 2D, or 3D? | Q47385958 | ||
| T2*-weighted magnetic resonance imaging with hyperoxia in acute ischemic stroke. | Q48150582 | ||
| Screening using whole-body magnetic resonance imaging scanning: who wants an incidentaloma? | Q48240756 | ||
| Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment | Q48312843 | ||
| Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study | Q48417159 | ||
| Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. | Q48471161 | ||
| CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. | Q48494001 | ||
| Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging. | Q51561367 | ||
| Brain and intracranial cavity volumes: in vivo determination by MRI. | Q52068572 | ||
| Prevalence of incidental pancreatic cysts in the adult population on MR imaging | Q57645260 | ||
| One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis | Q58642928 | ||
| Pathophysiologic basis of contrast enhancement in breast tumors | Q64025840 | ||
| Heterogeneity of stroke pathophysiology and neuroprotective clinical trial design | Q74254030 | ||
| Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease | Q77397493 | ||
| Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results | Q79674826 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 403-410 | |
| P577 | publication date | 2011-05-25 | |
| P1433 | published in | The EPMA journal | Q26842213 |
| P1476 | title | Magnetic resonance imaging and spectroscopy: how useful is it for prediction and prognosis? | |
| P478 | volume | 2 |
Search more.